vs
Side-by-side financial comparison of TOMPKINS FINANCIAL CORP (TMP) and USANA HEALTH SCIENCES INC (USNA). Click either name above to swap in a different company.
USANA HEALTH SCIENCES INC is the larger business by last-quarter revenue ($226.2M vs $194.8M, roughly 1.2× TOMPKINS FINANCIAL CORP). TOMPKINS FINANCIAL CORP runs the higher net margin — 49.4% vs 0.1%, a 49.3% gap on every dollar of revenue. On growth, TOMPKINS FINANCIAL CORP posted the faster year-over-year revenue change (152.7% vs -10.0%). Over the past eight quarters, TOMPKINS FINANCIAL CORP's revenue compounded faster (63.6% CAGR vs 3.1%).
Tompkins Financial Corporation is a small, diversified financial services company based in Ithaca, New York. It is the parent of the Tompkins Trust Company, as well as several other banks, an insurance agency, and a wealth management division.
Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors.
TMP vs USNA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $194.8M | $226.2M |
| Net Profit | $96.2M | $180.0K |
| Gross Margin | — | 78.2% |
| Operating Margin | 71.7% | 1.7% |
| Net Margin | 49.4% | 0.1% |
| Revenue YoY | 152.7% | -10.0% |
| Net Profit YoY | 388.9% | -74.0% |
| EPS (diluted) | $6.72 | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $194.8M | $226.2M | ||
| Q3 25 | $87.4M | $213.7M | ||
| Q2 25 | $82.6M | $235.8M | ||
| Q1 25 | $81.7M | $249.5M | ||
| Q4 24 | $77.1M | $213.6M | ||
| Q3 24 | $76.6M | $200.2M | ||
| Q2 24 | $72.7M | $212.9M | ||
| Q1 24 | $72.8M | — |
| Q4 25 | $96.2M | $180.0K | ||
| Q3 25 | $23.7M | $-6.5M | ||
| Q2 25 | $21.5M | $9.7M | ||
| Q1 25 | $19.7M | $9.4M | ||
| Q4 24 | $19.7M | $4.5M | ||
| Q3 24 | $18.6M | $10.6M | ||
| Q2 24 | $15.7M | $10.4M | ||
| Q1 24 | $16.9M | — |
| Q4 25 | — | 78.2% | ||
| Q3 25 | — | 77.2% | ||
| Q2 25 | — | 78.7% | ||
| Q1 25 | — | 79.0% | ||
| Q4 24 | — | 82.0% | ||
| Q3 24 | — | 80.4% | ||
| Q2 24 | — | 81.1% | ||
| Q1 24 | — | — |
| Q4 25 | 71.7% | 1.7% | ||
| Q3 25 | 35.6% | 0.6% | ||
| Q2 25 | 34.2% | 7.1% | ||
| Q1 25 | 31.6% | 6.3% | ||
| Q4 24 | 33.4% | 3.8% | ||
| Q3 24 | 32.0% | 7.8% | ||
| Q2 24 | 28.3% | 8.4% | ||
| Q1 24 | 30.4% | — |
| Q4 25 | 49.4% | 0.1% | ||
| Q3 25 | 27.1% | -3.1% | ||
| Q2 25 | 26.0% | 4.1% | ||
| Q1 25 | 24.1% | 3.8% | ||
| Q4 24 | 25.5% | 2.1% | ||
| Q3 24 | 24.3% | 5.3% | ||
| Q2 24 | 21.6% | 4.9% | ||
| Q1 24 | 23.2% | — |
| Q4 25 | $6.72 | $-0.10 | ||
| Q3 25 | $1.65 | $-0.36 | ||
| Q2 25 | $1.50 | $0.52 | ||
| Q1 25 | $1.37 | $0.49 | ||
| Q4 24 | $1.39 | $0.23 | ||
| Q3 24 | $1.30 | $0.56 | ||
| Q2 24 | $1.10 | $0.54 | ||
| Q1 24 | $1.18 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $132.8M | $158.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $938.4M | — |
| Total Assets | $8.7B | $742.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $132.8M | $158.4M | ||
| Q3 25 | $193.5M | $145.3M | ||
| Q2 25 | $212.6M | $151.3M | ||
| Q1 25 | $193.1M | $179.6M | ||
| Q4 24 | $134.4M | $181.8M | ||
| Q3 24 | $132.3M | $364.9M | ||
| Q2 24 | $70.9M | $332.4M | ||
| Q1 24 | $57.1M | — |
| Q4 25 | $938.4M | — | ||
| Q3 25 | $788.8M | $528.1M | ||
| Q2 25 | $761.8M | $531.1M | ||
| Q1 25 | $741.4M | $529.8M | ||
| Q4 24 | $713.4M | $532.1M | ||
| Q3 24 | $719.9M | $533.1M | ||
| Q2 24 | $674.6M | $512.2M | ||
| Q1 24 | $667.9M | — |
| Q4 25 | $8.7B | $742.9M | ||
| Q3 25 | $8.5B | $726.6M | ||
| Q2 25 | $8.4B | $734.5M | ||
| Q1 25 | $8.2B | $746.6M | ||
| Q4 24 | $8.1B | $748.2M | ||
| Q3 24 | $8.0B | $671.3M | ||
| Q2 24 | $7.9B | $631.4M | ||
| Q1 24 | $7.8B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $38.9M | — |
| Free Cash FlowOCF − Capex | $31.9M | — |
| FCF MarginFCF / Revenue | 16.4% | — |
| Capex IntensityCapex / Revenue | 3.6% | — |
| Cash ConversionOCF / Net Profit | 0.40× | — |
| TTM Free Cash FlowTrailing 4 quarters | $105.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $38.9M | — | ||
| Q3 25 | $34.9M | $-2.0M | ||
| Q2 25 | $18.9M | $12.2M | ||
| Q1 25 | $22.2M | $15.5M | ||
| Q4 24 | $95.0M | $5.8M | ||
| Q3 24 | $21.2M | $29.5M | ||
| Q2 24 | $27.3M | $8.0M | ||
| Q1 24 | $23.2M | — |
| Q4 25 | $31.9M | — | ||
| Q3 25 | $33.9M | $-5.2M | ||
| Q2 25 | $18.3M | $7.2M | ||
| Q1 25 | $20.9M | $12.7M | ||
| Q4 24 | $88.8M | $4.0M | ||
| Q3 24 | $18.9M | $27.1M | ||
| Q2 24 | $26.3M | $5.3M | ||
| Q1 24 | $21.9M | — |
| Q4 25 | 16.4% | — | ||
| Q3 25 | 38.8% | -2.4% | ||
| Q2 25 | 22.1% | 3.0% | ||
| Q1 25 | 25.5% | 5.1% | ||
| Q4 24 | 115.1% | 1.9% | ||
| Q3 24 | 24.7% | 13.6% | ||
| Q2 24 | 36.2% | 2.5% | ||
| Q1 24 | 30.0% | — |
| Q4 25 | 3.6% | — | ||
| Q3 25 | 1.1% | 1.5% | ||
| Q2 25 | 0.8% | 2.1% | ||
| Q1 25 | 1.7% | 1.1% | ||
| Q4 24 | 8.1% | 0.8% | ||
| Q3 24 | 2.9% | 1.2% | ||
| Q2 24 | 1.3% | 1.3% | ||
| Q1 24 | 1.9% | — |
| Q4 25 | 0.40× | — | ||
| Q3 25 | 1.47× | — | ||
| Q2 25 | 0.88× | 1.27× | ||
| Q1 25 | 1.13× | 1.65× | ||
| Q4 24 | 4.82× | 1.29× | ||
| Q3 24 | 1.14× | 2.78× | ||
| Q2 24 | 1.74× | 0.77× | ||
| Q1 24 | 1.38× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
